The impact of tranilast on restenosis after coronary angioplasty: The Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2)

American Heart Journal

Volumn 143, Issue 3, 2002, Pages 506-513

  Tamai, Hideo ^a   Katoh, Kazuzo ^a   Yamaguchi, Tetsu ^a   Hayakawa, Hirokazu ^a   Kanmatsuse, Katsuo ^a   Haze, Kazuo ^a   Aizawa, Tadanori ^a   Nakanishi, Shigemoto ^a   Suzuki, Shin ^a   Suzuki, Takahiko ^a   Takase, Shinichi ^a   Nishikawa, Hideo ^a   Katoh, Osamu ^a  

^a Shiga Medical Center for Adults   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANILAST;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SKIN MANIFESTATION; TRANSLUMINAL CORONARY ANGIOPLASTY; URINARY TRACT DISEASE;

EID: 0036187877     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120770     Document Type: Article

References (20)

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung and Blood Institute
2. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients
3. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months
4. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
5. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
6. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia
7. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients
8. Arterial injury and the enigma of coronary restenosis
9. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
10. Trapidil (Triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty: Results of the randomized, double blind STARC study
11. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty
12. Impact of tranilast on restenosis after coronary angioplasty: Tranilast restenosis following angioplasty trial (TREAT)
13. Effect of tranilast on prevention of chronic restenosis after PTCA
14. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty
15. Effectiveness of tranilast on restenosis after directional coronary atherectomy
16. Efficacy of tranilast on restenosis after coronary stenting
17. Late thrombosis after radiation: Sitting on a time bomb
18. Late coronary occlusion after intracoronary brachytherapy
19. Efficacy of tranilast on restenosis after coronary angioplasty: Is there any rebound phenomenon after ceasing tranilast at 3 months?
20. The PRESTO (Prevention of Restenosis with Tranilast and Its Outcomes) protocol: A double-blind, placebo-controlled trial